We are live on ! Find out more
TERN

Terns Pharmaceuticals
TERN

Delisted

TERN was delisted on the 4th of May, 2026.

Back to rankings

78 hedge funds and large institutions have $630M invested in Terns Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 26 increasing their positions, 15 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 14

73% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 15

40% more funds holding in top 10

Funds holding in top 10: 5 → 7 (+2)

25% more capital invested

Capital invested by funds: $505M → $630M (+$125M)

20% more funds holding

Funds holding: 65 → 78 (+13)

9.78% less ownership

Funds ownership: 103.68% → 93.9% (-9.8%)

Holders
78
Holders Change
+13
Holders Change %
+20%
% of All Funds
1.24%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.11%
New
27
Increased
26
Reduced
15
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
B
Braidwell
Connecticut
+$19.1M
2
PA
Perceptive Advisors
New York
+$12.9M
3
Franklin Resources
Franklin Resources
California
+$6.76M
4
Invesco
Invesco
Georgia
+$5.49M
5
BlackRock
BlackRock
New York
+$3.83M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$10.2M
2
DM
Deerfield Management
New York
-$7.57M
3
PVI
Pura Vida Investments
New York
-$6.16M
4
AC
Armistice Capital
New York
-$5.7M
5
JP Morgan Chase
JP Morgan Chase
New York
-$5.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
MFS
51
Mirabella Financial Services
United Kingdom
$395K +$319K +33,334 New
AA
52
ALPS Advisors
Colorado
$374K +$58.1K +6,078 +24%
Verition Fund Management
53
Verition Fund Management
Connecticut
$303K +$245K +25,590 New
Bank of New York Mellon
54
Bank of New York Mellon
New York
$241K +$195K +20,388 New
CSS
55
Cubist Systematic Strategies
Connecticut
$241K +$148K +15,491 +318%
JF
56
Jump Financial
Illinois
$217K +$175K +18,356 New
FAM
57
Fred Alger Management
New York
$193K +$156K +16,276 New
6CM
58
683 Capital Management
New York
$189K -$115K -12,000 -43%
LP
59
LMR Partners
United Kingdom
$188K +$151K +15,849 New
Man Group
60
Man Group
United Kingdom
$164K -$132K -13,763 Closed
Charles Schwab
61
Charles Schwab
California
$162K +$131K +13,711 New
Squarepoint
62
Squarepoint
New York
$153K +$124K +12,925 New
CF
63
Crosspoint Financial
California
$143K -$28.7K -3,000 -20%
Connor, Clark & Lunn Investment Management (CC&L)
64
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$142K +$114K +11,963 New
UBS Group
65
UBS Group
Switzerland
$67.2K +$54.2K +5,672 New
PMEF
66
Point72 Middle East FZE
United Arab Emirates
$60.2K +$48.6K +5,084 New
DFCM
67
Dark Forest Capital Management
Puerto Rico
$45.6K +$36.8K +3,852 New
TRCT
68
Tower Research Capital (TRC)
New York
$43K -$18.1K -1,889 -34%
Zurich Cantonal Bank
69
Zurich Cantonal Bank
Switzerland
$29.4K -$24.5K -2,568 -51%
CUAMC
70
China Universal Asset Management Company
China
$7.95K +$2.75K +288 +75%
Wells Fargo
71
Wells Fargo
California
$2.48K +$793 +83 +66%
TWA
72
TCI Wealth Advisors
Arizona
$2.37K +$1.91K +200 New
CAL
73
Capital Advisors Ltd
Ohio
$2K – – –
Daiwa Securities Group
74
Daiwa Securities Group
Japan
$2K – – –
PA
75
Parallel Advisors
California
$1.91K +$1.54K +161 New
1 2
3
4

TERN Hedge Fund Activity: Q1 2023 in Review

78 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Terns Pharmaceuticals (TERN) for Q1 2023, worth a combined $630M — up 25% from $505M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new TERN positions and 14 closed out — a net gain of 13 holders — while 26 added to existing stakes and 15 trimmed.

The largest buyer was Braidwell, opening a new position worth an estimated $19.1M. The largest seller was RTW Investments, exiting entirely with an estimated $10.2M sold.

  • 78 institutional investors held Terns Pharmaceuticals (TERN) as of Q1 2023, up from 65 in Q4 2022.
  • Funds reported $630M of Terns Pharmaceuticals stock for Q1 2023, up 25% quarter-over-quarter.
  • 27 funds opened new Terns Pharmaceuticals positions in Q1 2023 and 14 closed out, a net change of +13 holders.
  • The largest Terns Pharmaceuticals buyer in Q1 2023 was Braidwell, an estimated $19.1M added.
  • The largest Terns Pharmaceuticals seller in Q1 2023 was RTW Investments, an estimated $10.2M sold.

Based on aggregated 13F filings for Q1 2023.